Lexeo Therapeutics, Inc.
LXEO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001907108
In the last 90 days, Lexeo Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $410.9M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Lexeo Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 69
- +10 vs. Q2 2024
- Shares held
- 29.7M
- +3.95M (+15.3%) vs. Q2 2024
- Total value
- $268.8M
- −$144.8M (−35.0%) vs. Q2 2024
- New holders
- 16
- 36 more added
- Sold out
- 6
- 9 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LXEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 141 | $410.9M |
| Q1 2026 | 139 | $458.7M |
| Q4 2025 | 146 | $759.2M |
| Q3 2025 | 109 | $327.5M |
| Q2 2025 | 90 | $169.9M |
| Q1 2025 | 88 | $100.0M |
| Q4 2024 | 90 | $194.2M |
| Q3 2024 | 69 | $268.8M |
| Q2 2024 | 60 | $426.3M |
| Q1 2024 | 54 | $361.5M |
| Q4 2023 | 31 | $217.1M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Lexeo Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lazard Asset Management LLC | 33 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 10 | $0 | 0.00% | −6−37.5% | Reduced |
| SRS Capital Advisors, Inc. | 12 | $109 | 0.00% | 00.0% | Unchanged |
| Sterling Capital Management LLC | 27 | $244 | 0.00% | +27 | New |
| Steward Partners Investment Advisory, LLC | 100 | $904 | 0.00% | +100 | New |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 174 | $1.57K | 0.00% | +174 | New |
| FMR LLC | 595 | $5.38K | 0.00% | +460+340.7% | Added |
| Amalgamated Bank | 623 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,417 | $12.8K | 0.00% | −158−10.0% | Reduced |
| California State Teachers Retirement System | 1,735 | $15.7K | 0.00% | +993+133.8% | Added |
| Ameritas Investment Partners, Inc. | 2,387 | $21.6K | 0.00% | +1,364+133.3% | Added |
| Legal & General Group Plc | 2,527 | $22.8K | 0.00% | +1,517+150.2% | Added |
| Royal Bank of Canada | 3,153 | $28.0K | 0.00% | +2,186+226.1% | Added |
| New York State Common Retirement Fund | 4,187 | $37.9K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 4,848 | $43.8K | 0.00% | +288+6.3% | Added |
| BNP Paribas Arbitrage, SA | 5,541 | $50.1K | 0.00% | +3,591+184.2% | Added |
| Wells Fargo & Company | 7,442 | $67.3K | 0.00% | +4,101+122.7% | Added |
| Values First Advisors, Inc. | 7,446 | $67.3K | 0.04% | +7,446 | New |
| JPMorgan Chase & Co | 10,278 | $92.9K | 0.00% | +5,915+135.6% | Added |
| UBS Group AG | 11,112 | $100.5K | 0.00% | +7,983+255.1% | Added |
| Corebridge Financial, Inc. | 12,600 | $113.9K | 0.00% | +7,093+128.8% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 12,869 | $116.3K | 0.00% | +7,988+163.7% | Added |
| MetLife Investment Management | 14,223 | $128.6K | 0.00% | +7,803+121.5% | Added |
| Alliancebernstein L.P. | 15,970 | $144.4K | 0.00% | +5,220+48.6% | Added |
| Caxton Corp | 17,851 | $161.4K | 0.67% | 00.0% | Unchanged |
| Rhumbline Advisers | 21,070 | $190.5K | 0.00% | +7,713+57.7% | Added |
| Citigroup Inc | 23,105 | $208.9K | 0.00% | +11,560+100.1% | Added |
| PDT Partners, LLC | 26,608 | $240.5K | 0.02% | +26,608 | New |
| Jacobs Levy Equity Management, Inc | 30,346 | $274.3K | 0.00% | +30,346 | New |
| Prelude Capital Management, LLC | 30,725 | $277.8K | 0.02% | +30,725 | New |
| Jane Street Group, LLC | 35,677 | $322.5K | 0.00% | +8,918+33.3% | Added |
| Nuveen Asset Management, LLC | 36,050 | $325.9K | 0.00% | +17,757+97.1% | Added |
| Millennium Management LLC | 37,114 | $335.5K | 0.00% | −352−0.9% | Reduced |
| Bank of America Corp | 38,785 | $350.6K | 0.00% | +24,134+164.7% | Added |
| Bank of New York Mellon Corp | 47,983 | $433.8K | 0.00% | +16,177+50.9% | Added |
| Barclays PLC | 50,210 | $453.9K | 0.00% | +31,057+162.2% | Added |
| Wellington Management Group LLP | 51,892 | $469.1K | 0.00% | +29,791+134.8% | Added |
| ADAR1 Capital Management, LLC | 57,166 | $516.8K | 0.09% | +55,866+4,297.4% | Added |
| Polar Asset Management Partners Inc. | 59,800 | $540.6K | 0.01% | −5,500−8.4% | Reduced |
| Charles Schwab Investment Management Inc | 63,874 | $577.4K | 0.00% | +33,013+107.0% | Added |
| Goldman Sachs Group Inc | 76,751 | $693.8K | 0.00% | +49,898+185.8% | Added |
| Exome Asset Management LLC | 88,148 | $796.9K | 0.54% | +88,148 | New |
| Boothbay Fund Management, LLC | 107,484 | $971.7K | 0.03% | +107,484 | New |
| Perceptive Advisors LLC | 139,835 | $1.26M | 0.03% | +139,835 | New |
| Northern Trust Corp | 200,099 | $1.81M | 0.00% | +105,192+110.8% | Added |
| Morgan Stanley | 241,828 | $2.19M | 0.00% | +229,165+1,809.7% | Added |
| DAFNA Capital Management LLC | 250,583 | $2.27M | 0.54% | +250,583 | New |
| State Street Corp | 253,946 | $2.30M | 0.00% | +57,674+29.4% | Added |
| Ikarian Capital, LLC | 257,216 | $2.33M | 0.72% | +257,216 | New |
| Laurion Capital Management LP | 260,228 | $2.35M | 0.15% | −193,354−42.6% | Reduced |
| Point72 Asset Management, L.P. | 370,407 | $3.35M | 0.01% | +370,407 | New |
| Ra Capital Management, L.P. | 546,554 | $4.94M | 0.06% | −126,158−18.8% | Reduced |
| Geode Capital Management, LLC | 553,247 | $5.00M | 0.00% | +256,635+86.5% | Added |
| Siren, L.L.C. | 603,435 | $5.46M | 0.27% | +603,435 | New |
| Braidwell LP | 728,777 | $6.59M | 0.19% | −653,704−47.3% | Reduced |
| Verition Fund Management LLC | 777,320 | $7.03M | 0.05% | +355,928+84.5% | Added |
| Vestal Point Capital, LP | 850,000 | $7.68M | 0.61% | +10,000+1.2% | Added |
| Woodline Partners LP | 851,961 | $7.70M | 0.07% | +27,887+3.4% | Added |
| Vanguard Group Inc | 864,711 | $7.82M | 0.00% | +234,792+37.3% | Added |
| Novo Holdings A/S | 1,122,581 | $10.1M | 0.50% | −327,919−22.6% | Reduced |
| Blackstone Group Inc. | 1,158,617 | $10.5M | 0.05% | +352,860+43.8% | Added |
| Frazier Life Sciences Management, L.P. | 1,250,786 | $11.3M | 0.45% | +1,250,786 | New |
| BlackRock, Inc. | 1,630,287 | $14.7M | 0.00% | +1,630,287 | New |
| Eventide Asset Management, LLC | 1,855,986 | $16.8M | 0.29% | −1,513,161−44.9% | Reduced |
| Omega Fund Management, LLC | 2,355,904 | $21.3M | 13.31% | 00.0% | Unchanged |
| D1 Capital Partners L.P.SuperinvestorD1 Capital Partners | 2,506,607 | $22.7M | 0.44% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 2,597,736 | $23.5M | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,723,363 | $24.6M | 0.03% | +164,752+6.4% | Added |
| Janus Henderson Group PLC | 3,763,195 | $34.0M | 0.02% | +599,203+18.9% | Added |
| Artal Group S.A. | 0 | $0 | 0.00% | −603,435−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −132,187−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −14,035−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −10,542−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |